loading
전일 마감가:
$24.50
열려 있는:
$25.18
하루 거래량:
1.88M
Relative Volume:
1.59
시가총액:
$2.19B
수익:
$23.38M
순이익/손실:
$-155.22M
주가수익비율:
-11.42
EPS:
-2.19
순현금흐름:
$-134.36M
1주 성능:
+14.72%
1개월 성능:
+17.08%
6개월 성능:
+4.86%
1년 성능:
-40.98%
1일 변동 폭
Value
$24.76
$26.15
1주일 범위
Value
$21.50
$26.15
52주 변동 폭
Value
$13.45
$44.42

Ideaya Biosciences Inc Stock (IDYA) Company Profile

Name
명칭
Ideaya Biosciences Inc
Name
전화
650-443-6209
Name
주소
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Name
직원
131
Name
트위터
Name
다음 수익 날짜
2024-11-05
Name
최신 SEC 제출 서류
Name
IDYA's Discussions on Twitter

IDYA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IDYA
Ideaya Biosciences Inc
25.02 2.15B 23.38M -155.22M -134.36M -2.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-22 개시 TD Cowen Buy
2025-07-10 재개 Goldman Neutral
2025-06-26 개시 Wells Fargo Overweight
2024-11-18 개시 Stephens Overweight
2024-11-05 다운그레이드 Leerink Partners Outperform → Market Perform
2024-10-24 개시 UBS Buy
2024-10-15 개시 Cantor Fitzgerald Overweight
2024-07-08 개시 Mizuho Outperform
2024-03-08 개시 BTIG Research Buy
2023-08-08 개시 SVB Securities Outperform
2023-05-24 개시 Goldman Buy
2023-04-24 업그레이드 Stifel Hold → Buy
2023-03-23 개시 Berenberg Buy
2023-02-28 개시 RBC Capital Mkts Outperform
2022-12-28 개시 CapitalOne Overweight
2022-10-27 개시 Citigroup Buy
2022-08-15 다운그레이드 Stifel Buy → Hold
2022-07-18 재개 Oppenheimer Outperform
2022-03-10 업그레이드 Stifel Hold → Buy
2021-09-23 개시 Stifel Hold
2021-06-04 재개 Robert W. Baird Outperform
2021-03-11 개시 Guggenheim Buy
2020-10-07 개시 Wedbush Outperform
2020-09-01 개시 Northland Capital Outperform
2020-07-13 업그레이드 JP Morgan Neutral → Overweight
2020-06-17 재확인 H.C. Wainwright Buy
2020-04-06 개시 H.C. Wainwright Buy
2020-03-13 개시 ROTH Capital Buy
2019-10-17 개시 Oppenheimer Outperform
2019-09-10 개시 Robert W. Baird Outperform
2019-06-17 개시 Citigroup Buy
2019-06-17 개시 JP Morgan Neutral
2019-06-17 개시 Jefferies Buy
모두보기

Ideaya Biosciences Inc 주식(IDYA)의 최신 뉴스

pulisher
Jul 28, 2025

How volatile is IDEAYA Biosciences Inc. stock compared to the marketRetirement Planning Updates For Consistent Profits - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Chart based analysis of IDEAYA Biosciences Inc. trendsFree Fast Gaining Stock Screener Report - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Historical volatility pattern of IDEAYA Biosciences Inc. visualizedProven Trading System with Consistent Gains - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Why IDEAYA Biosciences Inc. stock attracts strong analyst attentionFree Price Action Based Buy Opportunity List - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Can IDEAYA Biosciences Inc. rally from current levelsSwing Entry Insight With Forecast Accuracy - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Analyzing net buyer seller activity in IDEAYA Biosciences Inc.Trade Flow Monitor with Volume Tracker - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Evaluating IDEAYA Biosciences Inc. with trendline analysisDaily Pick Forecast with Entry Zones - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What catalysts could drive IDEAYA Biosciences Inc. stock higher in 2025Unlock daily market insights for better decisions - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in IDEAYA Biosciences Inc. stockHigh-margin investment plays - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Will IDEAYA Biosciences Inc. stock benefit from AI tech trendsFree AI-Powered Stock Predictions - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Should I hold or sell IDEAYA Biosciences Inc. stock in 2025Invest smarter with data-backed trading alerts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

What drives IDEAYA Biosciences Inc. stock priceSignificant capital appreciation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

TD Cowen Bullish on Ideaya’s (IDYA) Oncology Pipeline - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Research Coverage Started at TD Cowen - Defense World

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about IDEAYA Biosciences Inc. stockTriple-digit profit margins - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is IDEAYA Biosciences Inc. a good long term investmentRecord-setting profit potential - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What makes IDEAYA Biosciences Inc. stock price move sharplyFree Investing Community - Newser

Jul 24, 2025
pulisher
Jul 24, 2025

IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma - The Malaysian Reserve

Jul 24, 2025
pulisher
Jul 24, 2025

IDEAYA to present phase 2 data on uveal melanoma drug at ESMO - Investing.com Nigeria

Jul 24, 2025
pulisher
Jul 24, 2025

IDEAYA to present phase 2 data on uveal melanoma drug at ESMO By Investing.com - Investing.com South Africa

Jul 24, 2025
pulisher
Jul 23, 2025

IDEAYA Biosciences Announces 10-Year Anniversary R&D Day on September 8, 2025 to Present Multiple Clinical Data Updates and Outline Future Growth Strategy - Nasdaq

Jul 23, 2025
pulisher
Jul 23, 2025

IDEAYA Biosciences: Precision Oncology Pipeline and Synthetic Lethality Catalysts - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

IDEAYA's First-in-Class Cancer Pipeline: Major Clinical Updates Coming at 10th Anniversary R&D Day - Stock Titan

Jul 23, 2025
pulisher
Jul 23, 2025

Signaturefd LLC Increases Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Jul 23, 2025
pulisher
Jul 23, 2025

IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADC - The Malaysian Reserve

Jul 23, 2025
pulisher
Jul 23, 2025

IDEAYA Biosciences Inc. Stock Analysis and ForecastHigh-margin investment plays - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Ideaya Biosciences, Hengrui announce oral presentation at IASLC 2025 - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Breakthrough Lung Cancer Drug IDE849 Shows First Human Results: 70+ Patient Data Coming at WCLC 2025 - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Melanoma Market Anticipates a Dynamic Shift During the Forecast Period (2025–2034) Owing to the Strong Pipeline Activity | DelveInsight - GlobeNewswire Inc.

Jul 22, 2025
pulisher
Jul 22, 2025

symbol__ Stock Quote Price and Forecast - CNN

Jul 22, 2025
pulisher
Jul 22, 2025

IDEAYA Biosciences: TD Cowen initiates coverage with Buy rating. - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Promising Pipeline and Strategic Focus Drive Buy Rating for IDEAYA Biosciences - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

TD Cowen initiates Ideaya Biosciences stock with Buy rating By Investing.com - Investing.com Canada

Jul 22, 2025
pulisher
Jul 22, 2025

TD Cowen Initiates Coverage of IDEAYA Biosciences (IDYA) with Buy Recommendation - MSN

Jul 22, 2025
pulisher
Jul 21, 2025

IDEAYA Biosciences CEO Fireside Chat: Precision Medicine Updates at BTIG Conference - Stock Titan

Jul 21, 2025

Ideaya Biosciences Inc (IDYA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
자본화:     |  볼륨(24시간):